72087-21-9 Usage
Uses
Used in Organic Synthesis:
6-(methylamino)nicotinaldehyde is used as a key intermediate in organic synthesis for the creation of a variety of bioactive molecules and pharmaceuticals. Its unique structure allows for versatile chemical reactions, facilitating the development of new compounds with potential applications in medicine.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 6-(methylamino)nicotinaldehyde is utilized as a starting material for the development of new drugs. Its chemical properties make it suitable for the synthesis of compounds with potential therapeutic effects, contributing to the advancement of medical treatments.
Used in Anticancer Research:
6-(methylamino)nicotinaldehyde is studied for its potential as an anti-cancer agent. Its effects on specific biological pathways and mechanisms are of interest to researchers seeking novel approaches to combat cancer, potentially leading to the discovery of new therapeutic agents.
Used in Neurotransmission Studies:
6-(methylamino)nicotinaldehyde has also been investigated for its impact on neurotransmission. Understanding its effects on neural communication could provide insights into the development of treatments for neurological disorders, making it a significant area of research in neuroscience.
Check Digit Verification of cas no
The CAS Registry Mumber 72087-21-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,0,8 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 72087-21:
(7*7)+(6*2)+(5*0)+(4*8)+(3*7)+(2*2)+(1*1)=119
119 % 10 = 9
So 72087-21-9 is a valid CAS Registry Number.
72087-21-9Relevant academic research and scientific papers
PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES
-
Page/Page column 88, (2008/06/13)
The invention relates to compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
